The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N05 | Psycholeptics | |
| 3 | N05B | Anxiolytics | |
| 4 | N05BB | Diphenylmethane derivatives |
| Code | Title | |
|---|---|---|
| N05BB01 | Hydroxyzine | |
| N05BB02 | Captodiame | |
| N05BB51 | Hydroxyzine, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Captodiame |
|
|
| Hydroxyzine |
Hydroxyzine is a first generation antihistamine, a piperazine derivative, with antimuscarinic and sedative properties. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ATARAX Film-coated tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
